GTBIF
Green Thumb Industries

5,945
Loading...
Loading...
News
all
press releases
Here's Why JAZZ Stock Is an Unconventional Cannabis Investment
Jazz Pharma is redefining cannabis investing with Epidiolex, a fast-growing FDA-approved epilepsy drug fueling its growth.
Zacks·5d ago
News Placeholder
More News
News Placeholder
Green Thumb Launches $50M Buyback: Time to Get Bullish on the Stock?
GTBIF launches a $50 million share buyback program, signaling confidence in long-term growth despite market and pricing pressures.
Zacks·12d ago
News Placeholder
Cannabis Stock CRLBF Gains 25% in a Month: Time to Buy, Sell or Hold?
CRLBF surges 25% this month on reform hopes, but revenue declines, margin pressure and stiff competition cloud its outlook.
Zacks·19d ago
News Placeholder
Cannabis Stock VRNOF Soars 178% in a Month: Time to Buy, Sell or Hold?
Verano's stock has surged 178% in a month on reform hopes, but pricing pressure and stiff competition test its momentum.
Zacks·1mo ago
News Placeholder
Trump Confirms Marijuana Reclassification Decision To Be Made In ‘Next Few Weeks’
The President noted that there’s a difference of opinion on the benefits of marijuana, but added that he’s heard “great things” with respect to medical marijuana, specifically.
Stocktwits·2mo ago
News Placeholder
Can Cannabis Stocks Reverse Their Prolonged Downtrend?
Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.
Zacks·2mo ago
News Placeholder
Green Thumb Industries Inc. (GTBIF) Reports Q2 Loss, Tops Revenue Estimates
Green Thumb Industries Inc. (GTBIF) delivered earnings and revenue surprises of -125.00% and +4.56%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Cannabis Operator CRLBF Plans California Exit: How to Play the Stock?
Cresco plans to exit California, citing tough market dynamics, as it sharpens focus on high-margin growth markets.
Zacks·2mo ago
News Placeholder
Cannabis Operator Green Thumb Down 30% YTD: Time to Buy, Sell or Hold?
GTBIF slides 30% YTD as rising costs, flat revenues and tight U.S. rules weigh on margins and investor sentiment.
Zacks·2mo ago

Latest GTBIF News

View

Advertisement|Remove ads.

Advertisement|Remove ads.